Literature DB >> 25851032

Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.

Christoph Loschen1, Andreas Klamt1,2.   

Abstract

OBJECTIVES: The fact that novel drug candidates are becoming increasingly insoluble is a major problem of current drug development. Computational tools may address this issue by screening for suitable solvents or by identifying potential novel cocrystal formers that increase bioavailability. In contrast to other more specialized methods, the fluid phase thermodynamics approach COSMO-RS (conductor-like screening model for real solvents) allows for a comprehensive treatment of drug solubility, solvate and cocrystal formation and many other thermodynamics properties in liquids. This article gives an overview of recent COSMO-RS developments that are of interest for drug development and contains several new application examples for solubility prediction and solvate/cocrystal screening.
METHODS: For all property predictions COSMO-RS has been used. The basic concept of COSMO-RS consists of using the screening charge density as computed from first principles calculations in combination with fast statistical thermodynamics to compute the chemical potential of a compound in solution. KEY FINDING: The fast and accurate assessment of drug solubility and the identification of suitable solvents, solvate or cocrystal formers is nowadays possible and may be used to complement modern drug development. Efficiency is increased by avoiding costly quantum-chemical computations using a database of previously computed molecular fragments.
SUMMARY: COSMO-RS theory can be applied to a range of physico-chemical properties, which are of interest in rational crystal engineering. Most notably, in combination with experimental reference data, accurate quantitative solubility predictions in any solvent or solvent mixture are possible. Additionally, COSMO-RS can be extended to the prediction of cocrystal formation, which results in considerable predictive accuracy concerning coformer screening. In a recent variant costly quantum chemical calculations are avoided resulting in a significant speed-up and ease-of-use.
© 2015 Royal Pharmaceutical Society.

Entities:  

Keywords:  COSMO-RS; cocrystals; liquid-phase thermodynamics; solubility prediction; solvates

Mesh:

Substances:

Year:  2015        PMID: 25851032     DOI: 10.1111/jphp.12376

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

Review 1.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

2.  Computational Screening of Drug Solvates.

Authors:  Christoph Loschen; Andreas Klamt
Journal:  Pharm Res       Date:  2016-07-28       Impact factor: 4.200

3.  Development of a high-throughput solubility screening assay for use in antibody discovery.

Authors:  Qing Chai; James Shih; Caroline Weldon; Samantha Phan; Bryan E Jones
Journal:  MAbs       Date:  2019-03-26       Impact factor: 5.857

4.  New Screening Protocol for Effective Green Solvents Selection of Benzamide, Salicylamide and Ethenzamide.

Authors:  Maciej Przybyłek; Anna Miernicka; Mateusz Nowak; Piotr Cysewski
Journal:  Molecules       Date:  2022-05-22       Impact factor: 4.927

5.  Exploring the cocrystallization potential of urea and benzamide.

Authors:  Piotr Cysewski; Maciej Przybyłek; Dorota Ziółkowska; Karina Mroczyńska
Journal:  J Mol Model       Date:  2016-04-06       Impact factor: 1.810

6.  In silico screening of dicarboxylic acids for cocrystallization with phenylpiperazine derivatives based on both cocrystallization propensity and solubility advantage.

Authors:  Piotr Cysewski
Journal:  J Mol Model       Date:  2017-03-27       Impact factor: 1.810

7.  Machine learning with physicochemical relationships: solubility prediction in organic solvents and water.

Authors:  Samuel Boobier; David R J Hose; A John Blacker; Bao N Nguyen
Journal:  Nat Commun       Date:  2020-11-13       Impact factor: 14.919

8.  Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening.

Authors:  João A Baptista; Mário T S Rosado; Ricardo A E Castro; António O L Évora; Teresa M R Maria; Manuela Ramos Silva; João Canotilho; M Ermelinda S Eusébio
Journal:  Molecules       Date:  2021-11-06       Impact factor: 4.411

9.  Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation.

Authors:  Andrea Mariela Araya-Sibaja; Cinira Fandaruff; Ana María Guevara-Camargo; Felipe Vargas-Huertas; William J Zamora; José Roberto Vega-Baudrit; Teodolito Guillén-Girón; Mirtha Navarro-Hoyos; Paola Paoli; Patrizia Rossi; William Jones
Journal:  ACS Omega       Date:  2022-04-19

Review 10.  A Novel Integrated Workflow for Isolation Solvent Selection Using Prediction and Modeling.

Authors:  Sara Ottoboni; Bruce Wareham; Antony Vassileiou; Murray Robertson; Cameron J Brown; Blair Johnston; Chris J Price
Journal:  Org Process Res Dev       Date:  2021-05-05       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.